Monday, June 15, 2026
ADVT 
National

Feds reject Rogers-Shaw deal, leave door open

Darpan News Desk The Canadian Press, 25 Oct, 2022 04:56 PM
  • Feds reject Rogers-Shaw deal, leave door open

OTTAWA — Industry Minister François-Philippe Champagne said he will not approve the proposed deal between Rogers Communications Inc. and Shaw Communications Inc., though he left the door open to a revised agreement.

The $26-billion proposed merger would have meant the wholesale transfer of wireless spectrum licences from Shaw to Rogers, which requires Champagne's approval.

“Today, I officially denied that request," he said Tuesday evening. “My decision formally closes that chapter of the original proposed transaction."

Shaw's ownership of Freedom Mobile has widely been seen as the main obstacle to the deal's approval, and Montreal-based Videotron earlier this year agreed to buy it for $2.85 billion.

But Champagne said before he would approve the Videotron deal, he requires additional concessions.

He said Videotron would have to agree to keep the Freedom wireless licences for at least 10 years.

"A new service provider needs to be in it for the long run," he said.

Secondly, he said he would "expect to see" wireless prices in Ontario and Western Canada lowered by about 20 per cent, putting them in line with Videotron's current Quebec offerings.

Champagne did not make clear whether a successful sale of Freedom Mobile would mean the Rogers-Shaw deal might be approved after all.

As well as Champagne's approval, the Rogers-Shaw deal requires a green light from the Competition Commissioner and the CRTC.

The Canadian Radio-television and Telecommunications Commission offered its conditional approval for the broadcasting portion of the deal in March.

The CRTC in March approved Rogers' acquisition of Shaw's broadcasting services, and laid out a series of conditions the company must meet. A mediation is scheduled for later this week between the Competition Commissioner and Rogers and Shaw.

MORE National ARTICLES

Protective equipment still scarce for some nurses

Protective equipment still scarce for some nurses
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.    

Protective equipment still scarce for some nurses

COVID-19 hospitalizations to surge: Tam

COVID-19 hospitalizations to surge: Tam
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.

COVID-19 hospitalizations to surge: Tam

Omicron upends mathematical models tracking COVID

Omicron upends mathematical models tracking COVID
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.

Omicron upends mathematical models tracking COVID

O'Toole opposes Quebec's plan to tax unvaccinated

O'Toole opposes Quebec's plan to tax unvaccinated
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.

O'Toole opposes Quebec's plan to tax unvaccinated

B.C. funds OD prevention in construction industry

B.C. funds OD prevention in construction industry
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.    

B.C. funds OD prevention in construction industry

Health Canada decision on Pfizer antiviral close

Health Canada decision on Pfizer antiviral close
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.

Health Canada decision on Pfizer antiviral close